The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’ immune systems to target cancer, leading to several FDA-approved treatments given to over 45,000 cancer patients, including many who had exhausted all other options and thousands who experienced remissions.
We are a research organization dedicated to understanding the roots of disease and closing the gap between new biological insights and impact for patients.
By uncovering the biology underlying heart disease, diabetes, cancer, and more, we’re helping to develop effective new treatments that target the root causes of these chronic diseases.
Members of the Data Sciences Platform build open-source technologies that help researchers everywhere connect to the patients, datasets, and tools they need to do life-changing science.
The Spatial Technology Platform expands the impact of spatial -omics through comprehensive support – from study design to data acquisition and processing – for a broad range of users. We also maintain an active research arm that develops and advances cutting edge spatial, imaging, and computational technologies.